BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12410848)

  • 1. Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy.
    Rincon-Choles H; Kasinath BS; Gorin Y; Abboud HE
    Kidney Int Suppl; 2002 Dec; (82):S8-11. PubMed ID: 12410848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia to nephropathy via transforming growth factor beta.
    Garud MS; Kulkarni YA
    Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM; Anderson S
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
    Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
    J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system within the diabetic podocyte.
    Márquez E; Riera M; Pascual J; Soler MJ
    Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of local and systemic angiotensin in diabetic renal disease.
    Anderson S
    Kidney Int Suppl; 1997 Dec; 63():S107-10. PubMed ID: 9407435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.
    Wolf G; Ziyadeh FN
    Am J Kidney Dis; 1997 Jan; 29(1):153-63. PubMed ID: 9002545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
    Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AGEs in diabetic nephropathy.
    Fukami K; Yamagishi S; Ueda S; Okuda S
    Curr Pharm Des; 2008; 14(10):946-52. PubMed ID: 18473844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic targets for diabetic nephropathy.
    Fukami K; Yamagishi S; Ueda S; Okuda S
    Endocr Metab Immune Disord Drug Targets; 2007 Jun; 7(2):83-92. PubMed ID: 17584148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular bases of diabetic nephropathy].
    Lagranha CJ; Fiorino P; Casarini DE; Schaan BD; Irigoyen MC
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):901-12. PubMed ID: 17934656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy: A potential savior with 'rotten-egg' smell.
    Dugbartey GJ
    Pharmacol Rep; 2017 Apr; 69(2):331-339. PubMed ID: 28183033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intrarenal renin-angiotensin system and diabetic nephropathy.
    Carey RM; Siragy HM
    Trends Endocrinol Metab; 2003 Aug; 14(6):274-81. PubMed ID: 12890592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy.
    Tan Y; Keum JS; Wang B; McHenry MB; Lipsitz SR; Jaffa AA
    Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1026-35. PubMed ID: 17596525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats.
    Portero-Otín M; Pamplona R; Boada J; Jové M; Gonzalo H; Buleon M; Linz W; Schäfer S; Tack I; Girolami JP
    Biochem Biophys Res Commun; 2008 Apr; 368(3):528-35. PubMed ID: 18243127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH
    Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease.
    Jerums G; Panagiotopoulos S; Forbes J; Osicka T; Cooper M
    Arch Biochem Biophys; 2003 Nov; 419(1):55-62. PubMed ID: 14568009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system.
    Lai KN; Leung JCK; Tang SCW
    Contrib Nephrol; 2011; 170():135-144. PubMed ID: 21659766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.